All filters
Slidesets
Monoclonal Antibodies for SARS-CoV-2 - Katharine Bar, MD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
SARS-CoV-2 Variants and Disease Severity - Robert Shafer, MD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
COVID-19 Therapeutics: State-Of-The-Art - Daniel Kuritzkes, MD
Presented at:
COVID-19 Clinical Management Workshop 2021
Slidesets
Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Antisense Oligos - L. Felton, Bsc, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Core Inhibitors (Capsid Assembly Modulators) - Luisa Stamm, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Biological Insights Taught by Clinical Responses to Novel Hbv-Hdv Drugs - S. Urban, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation - P. Mishra, MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
How to Handle Flares in HBV Trials With Novel Agents - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBsAg Loss. A Predictor of Long-Term Clinical Outcomes - M. Peters, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
A Novel Approach At Targeting the PD-1PD-l1 Pathway - PD-l1 Lna - A
Presented at:
International Workshop on HBV Cure 2021
Slidesets
HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci
Presented at:
International Workshop on HBV Cure 2021
Slidesets
VBI-2601 Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Immunotherapeutics in the Treatment of Chronic Hepatatis B - S. Browne, MD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Anti-HBs Antibody - C. Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
What Can We Learn by Deploying Immunological Analysis in Phase II Clinical Trials - A. Gehring, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Patient Selection for Clinical Trials Based on Drug Class - F. Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
New Data From Combination Trials for Chronic Hepatitis B - P. Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
New Combination Therapies in Hepatitis Delta Therapy - J. Glenn, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Slidesets
Novel Drug Delivery Systems on the Horizon - Charles Flexner, MD
Presented at:
HIV Prevention Summit 2021
Slidesets
Whatever Happened with PEP - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipGUM, DFSRH
Presented at:
HIV Prevention Summit 2021